Music |
Video |
Movies |
Chart |
Show |
Prof. Gilles Salles: Interim analysis of the JULIET study of CTL019 in R/R DLBCL (Lymphoma Hub) View | |
Data from the JULIET trial of CTL019 for relapsed or refractory diffuse large B-cell lymphoma (ecancer) View | |
Prof. Stephen J. Schuster, M.D.: CTL019 in R/R DLBCL – interim results interview from ICML 2017 (Lymphoma Hub) View | |
Six-month analysis of tisagenlecleucel in stubborn form of lymphoma shows sustained responses (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
The Use of CTL019 in Lymphoma (OncLive) View | |
Int Gilles Salles final low res (CANTORAMARIANAAVENA) View | |
Therapeutic targeting (Fondation Synergie Lyon Cancer) View | |
Results of the TRANSCEND study of CAR T Cell Product JCAR017 in patients with R/R aggressive B-NHL (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View | |
CAR-T Therapy for DLBCL (OncLive) View | |
ASHupdate 2012: Interview with Prof Stephen J Schuster, Teil 2 (Be Updated) View |